Adler A., Stratton I., Neil A. et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study . BMJ2000;321:412-19.
2.
British Hypertension Information Service Automatic Digital Blood Pressure Devices for Clinical use or Home Measurement. http://www.hyp.ac.uk/bhsinfo/bpmdigit.html
3.
Coats AJS , Radaelli A., Clark S., Conway J., Sleight P.The influence of ambulatory blood pressure monitoring on the design and interpretation of trials in hypertension. J Hypertension1992;10:385-91.
4.
Verdecchia P. , Schillaci G., Borgioni C. et al. White-coat hypertension: not guilty when correctly defined. Blood Press Monit1998;3:147-52.
5.
Ramsay L., Williams B., Johnston G. et al. Guidelines for the management of hypertension: report of the third working party of the British Hypertension Society. J Hum Hypertens1999;13:569-92.
6.
Estacio R., Schrier R.Anti-hypertensive therapy in type 2 diabetes: implications of the appropriate blood pressure control in diabetes (ABCD) trial. Am J Cardiol1998;12(9B):9R-14R.
7.
UKPDS 38. UK Prospective Diabetes Study Group.Tight blood pressure control and risk of microvascular and macrovascular complications in type 2 diabetes. BMJ1998;317:703-13.
